Were You Diagnosed with Cancer After Using Dupixent?
You may be entitled to significant compensation
Research published in JAMA Dermatology found that Dupixent users face a 4.5 times higher risk of developing cutaneous T-cell lymphoma (CTCL), a rare form of skin cancer.
If you used Dupixent for eczema or asthma and were later diagnosed with CTCL, mycosis fungoides, or Sézary syndrome, you may qualify for a lawsuit against manufacturers Sanofi and Regeneron.
Free Case Evaluation - No Cost Unless You Win
Answer 4 quick questions below (takes less than 2 minutes)
Did you use Dupixent for 3 or more months?
Which condition were you diagnosed with?
How long after starting Dupixent were you diagnosed?
Do you currently have an attorney for this case?
Get Your Free Case Review
Thank You!
We've received your information. An experienced attorney will contact you soon.
Office hours: Mon-Fri 9 AM - 5 PM EST